Location History:
- Fullerton, CA (US) (1998 - 2010)
- Bala Cynwyd, PA (US) (2010)
Company Filing History:
5 out of 31 
4 out of 3,688 
3 out of 790 
Years Active: 1998-2010
Title: Innovations in Gene Therapy: The Contributions of Gregory M. Podsakoff
Introduction
Gregory M. Podsakoff is a notable inventor based in Fullerton, CA, with a significant contribution to the field of gene therapy. He holds 12 patents, showcasing his innovative approaches to treating medical conditions, particularly anemia. His work has implications for the future of therapeutic treatments and gene delivery systems.
Latest Patents
Among his latest patents, Gregory has developed methods for treating anemia using recombinant adeno-associated virus (AAV) virions. This invention focuses on the delivery of DNA molecules to muscle cells and tissue, allowing for direct, in vivo injection of AAV virions into muscle tissue. The method enables sustained, high-level expression of erythropoietin, a critical protein for red blood cell production, and facilitates systemic delivery from transduced muscle cells. Another significant patent involves methods for delivering DNA to muscle cells using AAV virions, emphasizing the potential for in vitro transduction of muscle cells for therapeutic applications.
Career Highlights
Gregory has worked with prominent organizations such as Avigen, Inc. and The Johns Hopkins University. His experience in these institutions has contributed to his expertise in gene therapy and innovative treatment methods.
Collaborations
Throughout his career, Gregory has collaborated with esteemed colleagues, including Gary J. Kurtzman and Paul D. Kessler. These partnerships have furthered his research and development efforts in the field of gene therapy.
Conclusion
Gregory M. Podsakoff's contributions to gene therapy and his innovative patents highlight the potential for advanced treatments in medicine. His work continues to influence the landscape of therapeutic interventions for conditions like anemia.